Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10093910 Engineered CRISPR-Cas9 nucleases

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
December 5, 2016
Date of Patent
October 9, 2018
Patent Application Number
15369533
Patent Citations Received
‌
US Patent 12110545 Methods of assessing nuclease cleavage
0
‌
US Patent 12065668 RNA-guided targeting of genetic and epigenomic regulatory proteins to specific genomic loci
0
‌
US Patent 11499151 Methods and systems for analyzing guide RNA molecules
‌
US Patent 11236313 Cas9 fusion molecules, gene editing systems, and methods of use thereof
‌
US Patent 11597924 Genome editing systems comprising repair-modulating enzyme molecules and methods of their use
‌
US Patent 11624058 Engineered CRISPR-Cas9 nucleases with altered PAM specificity
0
‌
US Patent 11634731 Using truncated guide RNAs (tru-gRNAs) to increase specificity for RNA-guided genome editing
0
‌
US Patent 11286468 Engineered CRISPR-Cas9 nucleases with altered PAM specificity
‌
US Patent 11667911 Use of exonucleases to improve CRISPR/CAS-mediated genome editing
0
‌
US Patent 11680268 Methods for improving CRISPR/Cas-mediated genome-editing
0
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10093910
Patent Primary Examiner
‌
Karen Cochrane Carlson

Find more entities like US Patent 10093910 Engineered CRISPR-Cas9 nucleases

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo